Luminex Corporation To Present At UBS Global Healthcare Conference - WDRB 41 Louisville News

Luminex Corporation To Present At UBS Global Healthcare Conference

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Luminex Corporation

AUSTIN, Texas, May 1, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the UBS Global Healthcare Conference to be held May 19-21, 2014, in New York, NY.

Luminex logo.

The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 8:00 a.m. Eastern time on Monday, May 19, 2014.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Contacts:

Harriss T. Currie


Sr. Vice President, Finance and CFO


512-219-8020


hcurrie@luminexcorp.com




Matt Norman


Manager, Government and Investor Relations


512-336-3590


mnorman@luminexcorp.com

Logo - http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WDRB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.